Synergy between Toxoplasma gondii type I ΔGRA17 immunotherapy and PD-L1 checkpoint inhibition triggers the regression of targeted and distal tumors

• Jia Chen,
• Yu-Chao Zhu,
• Hany M Elsheikha,
• Jian-Hua Wang,
• Shuai Fang,
• Jun-Jun He,
• Xing-Quan Zhu

Affiliations

Jia Chen

1 Department of Radiology, The Affiliated Hospital of Medical School of Ningbo University, Ningbo, Zhejiang, China

Yu-Chao Zhu

1 Department of Radiology, The Affiliated Hospital of Medical School of Ningbo University, Ningbo, Zhejiang, China

Hany M Elsheikha

3 Faculty of Medicine and Health Sciences, School of Veterinary Medicine and Science, University of Nottingham, Sutton Bonington Campus, Loughborough, UK

Jian-Hua Wang

1 Department of Radiology, The Affiliated Hospital of Medical School of Ningbo University, Ningbo, Zhejiang, China

Shuai Fang

1 Department of Radiology, The Affiliated Hospital of Medical School of Ningbo University, Ningbo, Zhejiang, China

Jun-Jun He

4 State Key Laboratory of Veterinary Etiological Biology, Key Laboratory of Veterinary Parasitology of Gansu Province, Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Lanzhou, Gansu, China

Xing-Quan Zhu

5 College of Veterinary Medicine, Shanxi Agricultural University, Taigu, Shanxi, China